{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:03:54Z","timestamp":1786989834176,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402176"],"award-info":[{"award-number":["82402176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2025AFB802"],"award-info":[{"award-number":["2025AFB802"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.gene.2025.149949","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:30:02Z","timestamp":1765326602000},"page":"149949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gene therapy for Krabbe disease: evidence from mouse and canine models"],"prefix":"10.1016","volume":"980","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1497-7847","authenticated-orcid":false,"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1873-593X","authenticated-orcid":false,"given":"Ya-feng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.gene.2025.149949_b0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/hum.2017.151","article-title":"AAVrh10 Gene Therapy Ameliorates Central and Peripheral nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease)","volume":"29","author":"Bradbury","year":"2018","journal-title":"Hum. Gene Ther."},{"issue":"9","key":"10.1016\/j.gene.2025.149949_b0010","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1172\/JCI133953","article-title":"Krabbe disease successfully treated via monotherapy of intrathecal gene therapy","volume":"130","author":"Bradbury","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.gene.2025.149949_b0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymthe.2023.11.014","article-title":"Combination HSCT and intravenous AAV-mediated gene therapy in a canine model proves pivotal for translation of Krabbe disease therapy","volume":"32","author":"Bradbury","year":"2024","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.gene.2025.149949_b0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1167\/iovs.09-3847","article-title":"Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys","volume":"51","author":"Buie","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.gene.2025.149949_b0025","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/jgm.924","article-title":"Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain","volume":"8","author":"Dolcetta","year":"2006","journal-title":"J. Gene Med."},{"issue":"17","key":"10.1016\/j.gene.2025.149949_b0030","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.gt.3301541","article-title":"Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors","volume":"8","author":"Donsante","year":"2001","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.gene.2025.149949_b0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pediatrneurol.2011.05.007","article-title":"Early infantile Krabbe disease: results of the World-Wide Krabbe Registry","volume":"45","author":"Duffner","year":"2011","journal-title":"Pediatr. Neurol."},{"issue":"12","key":"10.1016\/j.gene.2025.149949_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0314858","article-title":"Human iPSC-derived myelinating organoids and globoid cells to study Krabbe disease","volume":"19","author":"Evans","year":"2024","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.gene.2025.149949_b0045","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1002\/bit.28412","article-title":"Critical challenges and advances in recombinant adeno-associated virus (rAAV) biomanufacturing","volume":"120","author":"Fu","year":"2023","journal-title":"Biotechnol. Bioeng."},{"issue":"8","key":"10.1016\/j.gene.2025.149949_b0050","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/jnr.22006","article-title":"Combined hematopoietic and lentiviral gene-transfer therapies in newborn Twitcher mice reveal contemporaneous neurodegeneration and demyelination in Krabbe disease","volume":"87","author":"Galbiati","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.gene.2025.149949_b0055","first-page":"599","article-title":"Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model","volume":"140","author":"Georgiou","year":"2017","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.gene.2025.149949_b0060","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1099\/0022-1317-83-5-973","article-title":"The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity","volume":"83","author":"Girod","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.gene.2025.149949_b0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","article-title":"AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset","volume":"25","author":"Goertsen","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.gene.2025.149949_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2014.09.046","article-title":"History, genetic, and recent advances on Krabbe disease","volume":"555","author":"Graziano","year":"2015","journal-title":"Gene"},{"issue":"16","key":"10.1016\/j.gene.2025.149949_b0075","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1523\/JNEUROSCI.4199-14.2015","article-title":"Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy","volume":"35","author":"Hawkins-Salsbury","year":"2015","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.gene.2025.149949_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/genes14081517","article-title":"Brain Targeted AAV1-GALC Gene Therapy Reduces Psychosine and Extends Lifespan in a Mouse Model of Krabbe Disease","volume":"14","author":"Herdt","year":"2023","journal-title":"Genes (Basel)"},{"issue":"9\u201310","key":"10.1016\/j.gene.2025.149949_b0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1089\/hum.2021.245","article-title":"Efficacy and Safety of a Krabbe Disease Gene Therapy","volume":"33","author":"Hordeaux","year":"2022","journal-title":"Hum. Gene Ther."},{"issue":"12","key":"10.1016\/j.gene.2025.149949_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121619","article-title":"A Novel Small NPC1 Promoter Enhances AAV-Mediated Gene Therapy in Mouse Models of Niemann-pick Type C1 Disease","volume":"12","author":"Hughes","year":"2023","journal-title":"Cells"},{"issue":"11\u201312","key":"10.1016\/j.gene.2025.149949_b0095","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jgm.2813","article-title":"Gene delivery targeted to oligodendrocytes using a lentiviral vector","volume":"16","author":"Kagiava","year":"2014","journal-title":"J. Gene Med."},{"issue":"11","key":"10.1016\/j.gene.2025.149949_b0100","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jnr.23882","article-title":"Intrathecal administration of AAV\/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant","volume":"94","author":"Karumuthil-Melethil","year":"2016","journal-title":"J. Neurosci. Res."},{"issue":"9","key":"10.1016\/j.gene.2025.149949_b0105","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/GIM.0b013e3181e85721","article-title":"Weighing the evidence for newborn screening for early-infantile Krabbe disease","volume":"12","author":"Kemper","year":"2010","journal-title":"Genet. Med."},{"issue":"16","key":"10.1016\/j.gene.2025.149949_b0110","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJM199804163381605","article-title":"Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy[J]","volume":"338","author":"Krivit","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.gene.2025.149949_b0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13023-018-0766-x","article-title":"Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease[J]","volume":"13","author":"Kwon","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.gene.2025.149949_b0120","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/hmg\/ddq099","article-title":"Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models","volume":"19","author":"Lattanzi","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.gene.2025.149949_b0125","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1093\/hmg\/ddu034","article-title":"Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy","volume":"23","author":"Lattanzi","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.gene.2025.149949_b0130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ymthe.2020.12.031","article-title":"Enhanced Efficacy and increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease","volume":"29","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.gene.2025.149949_b0135","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ymthe.2005.04.019","article-title":"AAV2\/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2","volume":"12","author":"Lin","year":"2005","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.gene.2025.149949_b0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.mt.6300026","article-title":"Central nervous system-directed AAV2\/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy","volume":"15","author":"Lin","year":"2007","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.gene.2025.149949_b0145","article-title":"Identification of AAV serotypes for gene therapy in Krabbe iPSCs-derived brain organoids","volume":"12","author":"Lv","year":"2025","journal-title":"Genes Dis"},{"issue":"3","key":"10.1016\/j.gene.2025.149949_b0150","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ymthe.2018.01.009","article-title":"Long-Term Improvement of Neurological signs and Metabolic Dysfunction in a Mouse Model of Krabbe's Disease after Global Gene Therapy","volume":"26","author":"Marshall","year":"2018","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.gene.2025.149949_b0155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2009.319","article-title":"Recent advances in lentiviral vector development and applications","volume":"18","author":"M\u00e1trai","year":"2010","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.gene.2025.149949_b0160","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/mt.2008.171","article-title":"Self-complementary AAV vectors; advances and applications","volume":"16","author":"McCarty","year":"2008","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.gene.2025.149949_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00443","article-title":"Gene therapy for the leukodystrophies: from preclinical animal studies to clinical trials[J]","volume":"21","author":"Metovic","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.gene.2025.149949_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030927","article-title":"Mechanotransduction Impairment in Primary Fibroblast Model of Krabbe Disease","volume":"11","author":"Mezzena","year":"2023","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.gene.2025.149949_b0175","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors[J]","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.gene.2025.149949_b0180","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/hum.2019.008","article-title":"An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice","volume":"30","author":"Pan","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.gene.2025.149949_b0185","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ymthe.2020.03.007","article-title":"AAV Capsid-Promoter Interactions Determine CNS Cell-Selective Gene Expression InVivo","volume":"28","author":"Powell","year":"2020","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.gene.2025.149949_b0190","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","article-title":"AAV vectors: the Rubik's cube of human gene therapy","volume":"30","author":"Pupo","year":"2022","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.gene.2025.149949_b0195","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ymthe.2004.12.020","article-title":"AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy","volume":"11","author":"Rafi","year":"2005","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.gene.2025.149949_b0200","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/mt.2012.153","article-title":"Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe disease","volume":"20","author":"Rafi","year":"2012","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.gene.2025.149949_b0205","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/mt.2015.145","article-title":"Long-term Improvements in Lifespan and Pathology in CNS and PNS after BMT Plus one Intravenous Injection of AAVrh10-GALC in Twitcher Mice","volume":"23","author":"Rafi","year":"2015","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.gene.2025.149949_b0210","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ymgme.2014.12.300","article-title":"Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features","volume":"114","author":"Rafi","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.gene.2025.149949_b0215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.34172\/bi.2021.21","article-title":"Can early treatment of twitcher mice with high dose AAVrh10-GALC eliminate the need for BMT?","volume":"11","author":"Rafi","year":"2021","journal-title":"Bioimpacts"},{"issue":"27","key":"10.1016\/j.gene.2025.149949_b0220","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1523\/JNEUROSCI.1802-11.2011","article-title":"Bone marrow transplantation augments the effect of brain- and spinal cord-directed adeno-associated virus 2\/5 gene therapy by altering inflammation in the murine model of globoid-cell leukodystrophy","volume":"31","author":"Reddy","year":"2011","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.gene.2025.149949_b0225","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/jnr.23752","article-title":"Perspective on innovative therapies for globoid cell leukodystrophy","volume":"94","author":"Ricca","year":"2016","journal-title":"J. Neurosci. Res."},{"issue":"12","key":"10.1016\/j.gene.2025.149949_b0230","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1093\/hmg\/ddv086","article-title":"Combined gene\/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy","volume":"24","author":"Ricca","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.gene.2025.149949_b0235","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jgm.719","article-title":"Widespread and highly persistent gene transfer to the CNS by retrovirus vector in utero: implication for gene therapy to Krabbe disease[J]","volume":"7","author":"Shen","year":"2005","journal-title":"J. Gene Med."},{"issue":"3","key":"10.1016\/j.gene.2025.149949_b0240","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to Viral Gene Therapy Vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"issue":"22","key":"10.1016\/j.gene.2025.149949_b0245","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1073\/pnas.1001673107","article-title":"A viral assembly factor promotes AAV2 capsid formation in the nucleolus","volume":"107","author":"Sonntag","year":"2010","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.gene.2025.149949_b0250","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0022-2275(20)34362-5","article-title":"Inhibition of cerebroside synthesis in the brains of mice treated with L-cycloserine","volume":"26","author":"Sundaram","year":"1985","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.gene.2025.149949_b0255","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1073\/pnas.66.2.302","article-title":"Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase","volume":"66","author":"Suzuki","year":"1970","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.gene.2025.149949_b0260","doi-asserted-by":"crossref","first-page":"E1894","DOI":"10.1002\/humu.21367","article-title":"Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease","volume":"31","author":"Tappino","year":"2010","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.gene.2025.149949_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/ph16040624","article-title":"rAAV2-Mediated Restoration of GALC in Neural Stem Cells from Krabbe Patient-Derived iPSCs","volume":"16","author":"Tian","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"10.1016\/j.gene.2025.149949_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065646","article-title":"Glial promoter selectivity following AAV-delivery to the immature brain","volume":"8","author":"von Jonquieres","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2025.149949_b0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fnmol.2016.00013","article-title":"Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes","volume":"9","author":"von Jonquieres","year":"2016","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.gene.2025.149949_b0280","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00401-017-1784-9","article-title":"Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy","volume":"135","author":"von Jonquieres","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.gene.2025.149949_b0285","article-title":"Dynein-regulated brain transduction of AAV.CAP-B10 via cerebral lateral ventricle enhances hippocampal function after traumatic brain injury through Ngf gene delivery in mice","author":"Wang","year":"2025391","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.gene.2025.149949_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.101937","article-title":"Generation of a human induced pluripotent stem cell line PUMCi001-a from a patient with Krabbe disease","volume":"48","author":"Wang","year":"2020","journal-title":"Stem Cell Res."},{"issue":"5","key":"10.1016\/j.gene.2025.149949_b0295","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"28","key":"10.1016\/j.gene.2025.149949_b0300","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.1073\/pnas.1117032109","article-title":"Induction of hepatocellular carcinoma by in vivo gene targeting","volume":"109","author":"Wang","year":"2012","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.gene.2025.149949_b0305","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1128\/JVI.78.12.6595-6609.2004","article-title":"Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus","volume":"78","author":"Warrington","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.gene.2025.149949_b0310","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuron.2020.03.031","article-title":"Macrophages Expressing GALC Improve Peripheral Krabbe Disease by a Mechanism Independent of Cross-Correction","volume":"107","author":"Weinstock","year":"2020","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.gene.2025.149949_b0315","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jnr.23743","article-title":"Krabbe disease: one Hundred years from the bedside to the bench to the bedside","volume":"94","author":"Wenger","year":"2016","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.gene.2025.149949_b0320","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s44321-024-00037-x","article-title":"Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor","volume":"16","author":"Xie","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.gene.2025.149949_b0325","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12887-015-0490-9","article-title":"Clinical and molecular report of novel GALC mutations in Moroccan patient with Krabbe disease: case report","volume":"15","author":"Zerkaoui","year":"2015","journal-title":"BMC Pediatr."},{"issue":"8","key":"10.1016\/j.gene.2025.149949_b0330","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/mt.2011.98","article-title":"Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.gene.2025.149949_b0335","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.molmed.2021.03.010","article-title":"Adeno-Associated Virus Vector for Central nervous System Gene Therapy","volume":"27","author":"Zhu","year":"2021","journal-title":"Trends Mol. Med."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925007395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925007395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:22:59Z","timestamp":1773919379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111925007395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":67,"alternative-id":["S0378111925007395"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2025.149949","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy for Krabbe disease: evidence from mouse and canine models","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2025.149949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149949"}}